Form 8-K - Current report:
SEC Accession No. 0001493152-24-006888
Filing Date
2024-02-15
Accepted
2024-02-15 17:00:24
Documents
18
Period of Report
2024-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50909
2 ex10-1.htm EX-10.1 290229
3 ex10-2.htm EX-10.2 30782
4 ex10-3.htm EX-10.3 120980
5 ex10-4.htm EX-10.4 30915
  Complete submission text file 0001493152-24-006888.txt   791723

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20240209.xsd EX-101.SCH 3015
7 XBRL LABEL FILE nrxs-20240209_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE nrxs-20240209_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3718
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24644650
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)